Fiducian Group Limited (ASX:FID) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall St
·3 min read

It looks like Fiducian Group Limited (ASX:FID) is about to go ex-dividend in the next 4 days. Typically, the ex-dividend date is one business day before the record date which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Fiducian Group investors that purchase the stock on or after the 27th of August will not receive the dividend, which will be paid on the 13th of September.

The company's next dividend payment will be AU$0.15 per share. Last year, in total, the company distributed AU$0.29 to shareholders. Calculating the last year's worth of payments shows that Fiducian Group has a trailing yield of 3.5% on the current share price of A$8.45. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. So we need to investigate whether Fiducian Group can afford its dividend, and if the dividend could grow.

Check out our latest analysis for Fiducian Group

Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Fiducian Group paid out more than half (69%) of its earnings last year, which is a regular payout ratio for most companies.

Generally speaking, the lower a company's payout ratios, the more resilient its dividend usually is.

Click here to see how much of its profit Fiducian Group paid out over the last 12 months.

historic-dividend
historic-dividend

Have Earnings And Dividends Been Growing?

Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. Fortunately for readers, Fiducian Group's earnings per share have been growing at 16% a year for the past five years.

The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Fiducian Group has increased its dividend at approximately 13% a year on average. It's great to see earnings per share growing rapidly over several years, and dividends per share growing right along with it.

The Bottom Line

Is Fiducian Group an attractive dividend stock, or better left on the shelf? Fiducian Group has an acceptable payout ratio and its earnings per share have been improving at a decent rate. Fiducian Group ticks a lot of boxes for us from a dividend perspective, and we think these characteristics should mark the company as deserving of further attention.

In light of that, while Fiducian Group has an appealing dividend, it's worth knowing the risks involved with this stock. To help with this, we've discovered 1 warning sign for Fiducian Group that you should be aware of before investing in their shares.

If you're in the market for dividend stocks, we recommend checking our list of top dividend stocks with a greater than 2% yield and an upcoming dividend.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Recommended Stories

  • Gildan Activewear Inc. (TSE:GIL) Looks Interesting, And It's About To Pay A Dividend

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

  • Is Teladoc Stock A Buy Now? Here's What Fundamentals, TDOC Stock Chart Say

    According to MarketSmith, the number of mutual funds owning a piece of Teladoc stock has climbed steadily.

  • Billionaire Dan Loeb Snaps Up These 2 “Strong Buy” Stocks

    Daniel Loeb, CEO of Third Point, has a reputation for turning risk into success. His preferred strategy – of going in and cleaning up the mess – has built his firm into a $17 billion-plus asset management behemoth, with both hands in the US and international equity and credit securities markets. In the current environment, as we’re getting buffeted about by epoch-making public health crises, economic disruptions, and now foreign policy political disasters, Loeb sees a combination of risk and vol

  • Why 2 Aerospace Giants Are Going to War Over This British Gem

    TransDigm Group (NYSE: TDG) is preparing a bid for British aerospace manufacturer Meggitt (LSE: MGGT), trying to break up Meggitt's planned sale to rival U.S. manufacturer Parker-Hannifin (NYSE: PH). TransDigm has submitted a preliminary, non-binding offer of 900 pence per share for Meggitt, a premium of 12.5% over Parker-Hannifin's 800-pence-per-share offer. Earlier this month, Meggitt agreed to be acquired by Parker-Hannifin in a deal worth about $8.7 billion.

  • Michael Burry’s Pretty Big Short Hinges on Treasuries Sinking

    (Bloomberg) -- Call it the Pretty Big Short. Michael Burry, whose huge, wildly profitable bets against the housing bubble were made famous in “The Big Short,” is wagering that long-term U.S. Treasuries will fall.His Scion Asset Management held $280 million of puts on the iShares 20+ Year Treasury Bond ETF at the end of June, according to a regulatory filing released this week, an increase from $172 million three months earlier.The options contracts would make money if TLT, as the exchange-traded

  • Al Gore’s Investment Firm Made Big Bets in Alibaba and Intel Stock

    Generation Investment, chaired by former Vice President Al Gore, loaded up on Alibaba ADRs and initiated a stake in chip giant Intel in the second quarter.

  • How An Institution Is Preparing For The Big Alibaba Rebound Play

    Alibaba Group Holding Ltd -ADR (NYSE: BABA) has been slaughtered since October 2020 when it reached an all-time high of $319.32. The sharp decline has been partly due to poor U.S./China relations as well and Chinese regulators cracking down on the e-commerce giant and its CEO Jack Ma. Since July 22 the decline in the stock has accelerated and although there has been some bounce plays for the bulls, the stock has become risky due to new out of China, when the U.S. markets are closed, causing Alib

  • 3 Dirt-Cheap Cannabis Stocks That Just Might Triple by 2023

    Marijuana is seen as one of the biggest growth markets around, even if many of its leading stocks have fallen far short of expectations. Once the cannabis industry finally does take off we may see all boats lifted by the rising tide, but Planet 13 Holdings (OTC: PLNH.F), Trulieve Cannabis (OTC: TCNNF), and the AdvisorShares Pure US Cannabis ETF (NYSEMKT: MSOS) may have already tripled in value by then. Alex Carchidi (Planet 13 Holdings): If you've ever visited the Las Vegas Strip, you've probably seen or even experienced Planet 13's flagship cannabis superstore, where more than a million tourists flocked to buy marijuana in 2019.

  • 5 Top Stocks That Can Turn $200,000 Into $1 Million (or More) by 2035

    Time and again, Wall Street has demonstrated that it handsomely rewards patient investors. In other words, buying great companies and allowing your investment thesis to play out over time continues to be a successful wealth-building strategy. The first top stock that could make patient investors a lot richer by 2035 is Singapore-based Sea Limited (NYSE: SE).

  • 3 Boring Healthcare Stocks Everyone Should Own

    These pharmaceutical giants offer strong, dependable dividends and the size to weather the market's ups and downs.

  • Got $5,000? 3 Beaten-Down Cathie Wood Stocks That Could Soar

    Cathie Wood was the darling of Wall Street last year as her ARK funds smashed the returns of the overall market. Let's find out why they think you should take a hard look at Twilio (NYSE: TWLO), Roku (NASDAQ: ROKU), and Zoom Video Communications (NASDAQ: ZM). Will Healy (Twilio): Twilio has become one of the more significant holdings in Cathie Wood's ARK Innovation ETF and two other ARK Invest funds.

  • 10 Best Dividend Stocks Hedge Funds are Buying

    In this article, we will be taking a look at the 10 best dividend stocks hedge funds are buying. To skip our detailed analysis of dividend investing, you can go directly to see the 5 Best Dividend Stocks Hedge Funds are Buying. Dividend investing is something that must be done with care and great deliberation. […]

  • Here's My Favorite Dividend Stock to Buy Right Now

    The older I get, the more appealing dividend stocks are. There are plenty of alternatives that provide great dividends and strong growth potential. Here's my favorite dividend stock to buy right now.

  • Will Coupang Be a Trillion-Dollar Stock by 2030?

    Coupang (NYSE: CPNG), the largest e-commerce company in South Korea, went public this March at $35 per share. Coupang's stock recently dipped below its IPO price after it posted a messy second-quarter report. Concerns about Coupang's lack of profits, its ability to expand beyond South Korea, and tougher post-pandemic comparisons for e-commerce companies exacerbated that sell-off.

  • Buffett’s Berkshire Still Isn’t Buying. Here’s What It Sold.

    Warren Buffett’s company trimmed its holdings in three pharma stocks, GM, and Chevron—but bought its own shares.

  • 3 Retail Stocks With Juicy Dividends You Can Buy Right Now

    Investors win big with stocks that offer potential for capital appreciation and tempting shareholder payouts.

  • Three Things That Tell Me Lordstown Motors Is in Deep Trouble

    With the founder gone, those left behind are scrambling to turn what's left into a real business.

  • This Growth Stock Could Triple by 2026

    After that massive run, it's natural to wonder how much higher Sea can rise. Sea Limited operates across seven countries in Southeast Asia and Taiwan, an area with one of the fastest-growing economies in the world. More specifically, Sea is a holding company that owns three distinct businesses, each of which hits on a major secular trend.

  • It's Time to Buy These 3 Beaten-Down Tech Stocks

    There is no one-size-fits-all solution, but if you've done the research and you still feel confident in the company, those downturns are often a buying opportunity. Keep reading to see why Appian (NASDAQ: APPN), Stitch Fix (NASDAQ: SFIX), and Verizon (NYSE: VZ) made the list. Trevor Jennewine (Appian): Microsoft CEO Satya Nadella once said, "Every company is a software company."

  • 1 Smart Way to Invest in Dogecoin Without Buying Cryptocurrency

    Dogecoin's price is starting to climb: Here's one strategy that could help investors capitalize on that trend.